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Abstract:

Keywords:

In the present study we aimed to perform the first analysis of antimicrobial activity of bacteria
isolated from Krubera-Voronja Cave, with the main focus on their activity against Grampositive bacteria, including Gram-positive pathogens. Using five different media, in total
874 heterotrophic cultures were isolated from water and sediment samples collected in
Krubera-Voronja Cave at a depth from 220 m to 1640 m. 14.0% of all isolates demonstrated
antibacterial activity against Gram-positive and Gram-negative test microorganisms. Our
results show that this percentage was not uniform; it increased with the sampling depth and
was the highest in the lower part of the cave. 24 isolates were active exclusively against
Gram-positive test strains Micrococcus luteus and Bacillus thuringiensis. Two isolates,
namely strains 1350R2-TSA30-6 and 1410WF1-TSA30-2, were chosen for the further work
because of the high and comparable activity against both Gram-positive test microorganisms.
It was determined that both strains belong to the family Bacillaceae in phylum Firmicutes. The
detailed bioactivity analysis of these two Gram-positive strains revealed the different mixtures
of volatile compounds with antibacterial activity. The main antibacterial compounds of the
strain 1350R2-TSA30-6 are pyrrolopyrazines pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro3-(2-methylpropyl)- and pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(phenylmethyl)-. The
main antibacterial compound of the strain 1410WF1-TSA30-2 is 1,2-benzenedicarboxylic
acid, bis(2-methylpropyl) ester. Mixtures of the volatile antimicrobial compounds of both
strains were antagonistic against Gram-positive strains isolated from Krubera-Voronja Cave,
and their activity against Gram-positive pathogenic bacteria substantially differed.
antimicrobial, Bacillus, cave microorganisms, Krubera-Voronja Cave, volatile compound
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INTRODUCTION
Antibiotic resistance of pathogenic bacteria became
one of the greatest threats to human health over the
last few decades (Blair et al., 2015). A few different
approaches are used to resolve this problem: chemical
synthesis of novel antibiotics (Wright et al., 2014),
discovery and development of novel agents capable of
circumventing or neutralizing the existing resistance
mechanisms (Blair et al., 2015), as well as search for
new natural antimicrobials (Lamprinou et al., 2015).
Considering the last-mentioned approach, caves
represent one of the most attractive environments
with a strong potential for the discovery of novel
antimicrobials. Antimicrobial activity of different
cave microorganisms against pathogenic bacteria
*nomeda.kuisiene@gf.vu.lt

was reported previously (Herold et al., 2005; Nakaew
et al., 2009; Rajput et al., 2012; Cheeptham et al.,
2013; Rule & Cheeptham, 2013; Tomova et al., 2013;
Lamprinou et al., 2015); a new genus of bacteria,
producing antimicrobial substances, was identified in
a cave in Thailand (Nakaew et al., 2012).
Ecological conditions enabling cave microorganisms
to produce antimicrobial compounds are unclear.
Montano & Henderson (2013) showed that the
frequency of human visitation does not affect the
antimicrobial activity of cave microorganisms, while
the increasing depth, and consequently increasing
oligotrophy do. Energy-starved conditions in the
caves prompt the complex interactions (competitive
or cooperative) between different microorganisms
resulting in the production of secondary metabolites,
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such as pigments, siderophores, and antibiotics,
which are used as informational cues (Rajput et al.,
2012; Gabriel & Northup, 2013). Krubera-Voronja
Cave is the Earth’s deepest cave (Sendra & Reboleira,
2012). Because of its depth, high antimicrobial activity
of microorganisms living in it could be expected, but it
has not been investigated so far.
Antimicrobial potential of cave actinobacteria and
especially Streptomyces was investigated (Herold
et al., 2005; Nakaew et al., 2009; Hodges et al.,
2012; Rajput et al., 2012; Cheeptham et al., 2013;
Rule & Cheeptham, 2013; Nimaichand et al., 2015),
but the antimicrobial compounds of bacteria from
other phyla – Cyanobacteria (Lamprinou et al.,
2015), Proteobacteria and Bacteroidetes (Tomova
et al., 2013) – were also of scientific interest. Our
previous cultivation-independent analysis of bacterial
diversity in Krubera-Voronja Cave showed that
Gram-positive phyla Actinobacteria and Firmicutes
were among the most numerous phyla in this cave
(Kieraite-Aleksandrova et al., 2015). This indicates
during the evolution the indigenous Gram-positive
bacteria of Krubera-Voronja Cave could have evolved
the mechanisms to compete and/or collaborate
specifically with other Gram-positive bacteria. The
production of antimicrobial compounds could be
regarded as one of those mechanisms. Antimicrobial
activity of the indigenous Gram-positive bacteria of
Krubera-Voronja Cave against other Gram-positive
bacteria is still unknown and should be evaluated,
the rather that the search for novel antimicrobials
targeting Gram-positive pathogens is of major
importance. These bacteria most commonly cause
severe nosocomial infections, and the resistance of
these pathogens to conventionally used antimicrobials
continuously increases and strengthens (Herold et
al., 2005). Therefore, screening for novel narrowspectrum antimicrobials, that would be active against
Gram-positive pathogens, is vital.
In the present study we aimed to perform the first
analysis of antibacterial activity of microorganisms
isolated from Krubera-Voronja Cave, mainly focusing
on their activity against Gram-positive bacteria
including Gram-positive pathogens.

MATERIAL AND METHODS
Site description and sampling
Krubera-Voronja Cave is located in the Arabica
Massif (43.4184 N 40.3083 E, Western Caucasus).
Sampling in Krubera-Voronja Cave was described
explicitly in our previous work (Kieraite-Aleksandrova
et al., 2015). It was performed on 30th July to 7th
August 2012, at depths of 220 m to 1640 m. At the
time of sampling, humidity ranged from 69-76% in
the upper part (220-230 m in depth) of the cave to
>90% in the middle (500-700 m in depth) and the
lower (1215-1640 m in depth) parts of the cave. The
temperature in the cave ranged from 3-4°C in the
upper and middle parts to 6-8°C in the lower part
of the cave.
In total, 26 samples were collected from KruberaVoronja Cave. The collected sample materials

included soil and clay from cave walls, sediment,
speleothems, drinkable water from the underground
camps as well as coloured spots from cave walls. All
samples were collected using aseptic techniques and
placed into sterile microcentrifuge tubes. The samples
were transported in a cooler and stored at -20°C until
microbial analysis was performed.
Isolation of bacterial cultures
For isolation of culturable microorganisms
from water samples, 100 μL of each sample was
spread over different solid microbiological media
dispensed in Petri dishes. For isolation of culturable
microorganisms from sediment samples, 300 mg
of each sample was suspended in 700 μL of saline,
and 100 μL of each suspension was spread over
different solid microbiological media. Tryptic Soy
agar (TSA) (Merck Millipore), Hickey-Tresner (HT)
agar, Actinomycetes Isolation (AI) agar, Starch Casein
Nitrate agar (SCNA), and Difco™ ISP medium 4 (ISP4)
were used. The cultivation media were selected
according to Cheeptham et al. (2013) and Hodges
et al. (2012) as well as the previous data on the
bacterial diversity in Krubera-Voronja Cave (KieraiteAleksandrova et al., 2015). It was previously shown
that Actinobacteria, Firmicutes, and Proteobacteria
were the dominant phyla in this cave. HT agar, AI
agar, SCNA and ISP4 are usually used for the isolation
and cultivation of Actinobacteria, and TSA is routinely
used for the isolation and cultivation of Firmicutes
and Proteobacteria. Two different temperatures were
chosen for the isolation of microorganisms from
the cave samples: 4°C and 30°C. The first one was
selected according to the temperature profile inside
the cave (3-8°C, see above); it is suitable for the
growth of psychrophiles that were believed to thrive
in the cave. The second temperature is suitable for
the growth of psychrotolerant microorganisms that
have an optimum temperature between 20°C and
40°C, but could be metabolically active at the cave’s
temperature. Microorganisms were cultivated at
4°C for 7 days and at 30°C for 3 days. Only those
microorganisms that stood apart in colony morphology
and in ability to excrete soluble pigments were chosen
for further work.
Primary screening of microbial isolates for
antibacterial activity
In order to identify microbial isolates with
antibacterial activity, a modified version of agar
diffusion test (cross-streak assay) was used (Montano
& Henderson, 2013). Cave microorganisms were
streaked and cultivated under the same conditions
and on the same solid medium which they were
isolated. For example, bacterial cultures 1350R2TSA30-6 and 1410WF1-TSA30-2 were initially isolated
on TSA at 30°C. Therefore, for the primary screening
for antibacterial activity, they were restreaked on TSA
and cultivated at 30°C. For screening, the plates with
the streaks of the cave microorganisms were covered
with a layer of sterile TSA. Test microorganisms were
streaked on sterile TSA perpendicularly to the already
grown streaks of the cave microorganisms. Test
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microorganisms were cultivated at 30°C for 24 h. The
zone of growth inhibition of the test microorganisms
near the cave isolate streak indicated antimicrobial
activity of the cave microorganisms. No inhibition
was defined as absent interruption of the target test
microorganism streak where it crossed the cave isolate
streak. Gram-positive (Micrococcus luteus and Bacillus
thuringiensis TL8) and Gram-negative (Escherichia
coli BL21(DE3) and Pseudomonas sp. VR1) bacteria
served as test microorganisms.

was mixed with molten TSA to achieve final 10 CFU/
mL. Inoculated TSA was poured into the Petri dishes
(20 mL per dish). 5 mm diameter wells were cut in
the inoculated agar surface and filled with 100 μL
of the sample. The zone of the growth inhibition of
test microorganisms indicated antimicrobial activity
of the sample and was recorded as a zone diameter
(in millimeters) around the wells, minus 5-mm
diameter of the well (Choma & Grzelak, 2011; Tomova
et al., 2013).

Genotyping of the active isolates
The bacterial genomic DNA was extracted from
fresh cell culture using the GeneJET™ Genomic DNA
Purification Kit (Thermo Fisher Scientific) according
to the manufacturer’s instructions. BOX-PCR was
performed in 50 μL of reaction mixture containing
DreamTaq Green PCR Master Mix (2X) (Thermo Fisher
Scientific), 0.5 μM BOXA1R primer (5’-CTA CGG CAA
GGC GAC GCT GAC G-3’) and 10 ng of bacterial
genomic DNA. BOX-PCR was conducted under the
following conditions: initial denaturation at 95°C for
2 min followed by 29 cycles, each consisting of 95°C
for 1 min, 53°C for 2 min, and 72°C for 3 min with
a final extension step at 72°C for 7 min. Products
of amplification were analysed by electrophoresis
through 1% agarose gel.

Optimization of culture growth parameters for
production of antibacterial compounds
Effects of the concentration of nutrients, growth
medium pH, temperature and aeration on the
culture growth were examined in order to optimize
the production of antibacterial compounds. Effects
of the concentration of nutrients were examined
using 1xTryptic Soy broth (TSB), 0.5xTSB and highly
nutritious growth medium Brain Heart Infusion broth
(BHIB). To test the effect of pH, growth medium was
prepared in 50 mM Tris-HCl buffer (pH 7, 8, and
9/20°C). For determination of the effect of temperature,
30°C (the isolation temperature), 16°C, 8°C (the upper
temperature limit of the cave), and 4°C (the lower
temperature limit of the cave) were chosen. The effect
of aeration was determined at 180 rpm and 250 rpm
in an orbital shaker Multitron Standard (INFORS HT).
Inoculation (5% vol/vol) was performed using
bacterial cultures grown for 12 h on TSA plates at
30°C. Inocula were prepared in the respective sterile
growth medium. Bacteria were cultivated in 250 mL
Erlenmeyer flasks, and the samples were aseptically
removed every 2 h to determine culture growth and
production of antimicrobial compounds. Growth of the
culture was monitored by measuring optical density
at 600 nm, and antimicrobial activity of the culture
was assayed in the culture supernatant by agar-well
diffusion method (see above). Cells from the liquid
culture were removed by centrifugation (7000×g, 20
min, 4°C).

Phylogenetic analysis of active isolates
Amplification of 16S rRNA genes was done according
to Kuisiene et al. (2002). PCR products were cloned
into E. coli DH5α using the CloneJET™ PCR Cloning
Kit (Thermo Fisher Scientific). Recombinant plasmids
were isolated using the GeneJET™ Plasmid Miniprep
Kit (Thermo Fisher Scientific). 16S rRNA genes of
strains 1350R2-TSA30-6 and 1410WF1-TSA30-2 were
sequenced at the DNA Sequencing Centre (Vilnius
University, Institute of Biotechnology, Lithuania);
the obtained sequences were edited and sequence
similarity was determined using the SEQBUILDER
and MEGALIGN components of LASERGENE 6
(DNASTAR). 16S rRNA gene sequences were subjected
to phylogenetic analysis using ARB (Ludwig et al.,
2004). The size of the 16S rRNA gene used for the
analysis was 1372 nt. The tree was rooted using the
16S rRNA gene sequence of Paenibacillus polymyxa
DSM 36T as an outgroup.
Nucleotide sequence accession numbers
16S rRNA gene sequences of strains 1350R2TSA30-6 and 1410WF1-TSA30-2 were deposited in
the GenBank under the No. KU513788 and KU513789
respectively.
Evaluation of antimicrobial activity of active
isolates by agar-well diffusion method
Test microorganisms were cultivated on TSA medium
at 30°C for 24 h and then resuspended in saline. The
correlation between the optical density of bacterial
suspensions at 600 nm and the number of CFU/mL
after the TSA plate counts was established for test
microorganisms. For the evaluation of antimicrobial
activity, the suspension of the test microorganism

6

Extraction of antibacterial compounds by saltingout with ammonium sulphate
Active bacterial strains were cultivated in buffered
0.5xTSB for 12 h at 30°C at 180 rpm in the orbital
shaker Multitron Standard (INFORS HT). Cells
were removed by centrifugation (7000×g, 20 min,
4°C), and solid ammonium sulphate was added to
the supernatant to achieve 80% saturation. The
precipitate was recovered by centrifugation (12000×g,
20 min, 4°C), then dissolved in 20 mM Tris-HCl
buffer (pH 7). The dissolved proteins were evaluated
for the antimicrobial activity using agar-well
diffusion method. The dissolved proteins were also
treated with recombinant proteinase K (Thermo
Fisher Scientific) according to the manufacturer’s
instructions. Antimicrobial activity of hydrolysed
proteins was also evaluated using agar-well diffusion
method. Protein concentration was determined
using the Pierce™ Coomassie (Bradford) Protein
Assay Kit (Thermo Fisher Scientific) according to the
manufacturer’s instructions.
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Extraction of antibacterial compounds by organic
solvents
Active strains were cultivated in 100 mL of buffered
0.5xTSB for 12 h at 30°C at 180 rpm in the orbital
shaker Multitron Standard (INFORS HT). Cells were
removed by centrifugation (7000×g, 20 min, 4°C).
Antibacterial compounds in the supernatant were
extracted with equal volume of acetone, chloroform,
ethyl acetate, methanol, and hexane in a separating
funnel. Different supernatant samples of the same
culture were separately extracted with each solvent.
The organic solvent extracts were evaporated to
dryness and dissolved in chloroform (Sanghvi et al.,
2014).
Thin layer chromatography and bioautography
Thin layer chromatography (TLC) of chloroform
extract was done on Silica gel 60 F254 plates (Merck
Millipore). The antibacterial compounds were
separated with ethyl acetate-methanol (3:1, vol/vol)
solvent system. Chromatograms were observed under
UV light and exposed to iodine vapours. Bioautography
was used for the localization of antibacterial
compounds in chloroform extract (Attimarad et al.,
2012). TLC plate with the separated antibacterial
compounds was dried, put in sterile Petri dish, and
overlaid with the inoculated TSA. Inoculated TSA was
prepared as described above for the agar well diffusion
method. M. luteus was used for bioautography as the
test microorganism. After incubation at 30°C for 24 h,
the zone of inhibition around the spot of antibacterial
compound was determined. The fractions with
antibacterial activity were recovered from TLC plates,
disssolved in ethyl acetate and subjected to further
analysis.
Gas chromatography-mass spectrometry (GC-MS)
analysis of antibacterial compounds
Gas chromatographic (GC) analysis of the fractions
with antibacterial activity recovered from TLC plates
was performed on a PerkinElmer Clarus 580 series gas
chromatograph coupled to a PerkinElmer Clarus 560
S mass spectrometer (PerkinElmer, Shelton, USA).
The GC system was equipped with Elite-5MS capillary
column (30 m × 0.25 mm id, 0.25 µm film thickness)
coated with methylpolysiloxane (5% phenyl). Helium
was employed as a carrier gas with a constant flow of
1 mL/min. GC conditions were as follows: the oven
temperature was programmed: 40°C for 1 min, from
40 to 250°C at 3°C/min and held at 250°C for 8 min;
the injector temperature was held at 250°C. Injection
was performed in pulsed splitless mode (pulsed to 4
mL/min until 1.5 min, split (10:1) open at 1.55 min).
The capillary column was connected to the ion source
of the mass spectrometer by means of the transfer
line maintained at 280°C. The electron ionization ion
source conditions were: electron energy 70 eV and
temperature 180°C. GC-MS in full scan mode was
used. The analyses were carried out with a filament
multiplier delay of 3 min, and the acquisition was
performed in the range of m/z 33 ‑ 600. The qualitative
identification of different compounds was performed
by comparing their mass spectra with those stored

in the NIST (The National Institute of Standards and
Technology) library. The relative amounts of individual
compounds were expressed as percentages of the peak
area relative to the total peak area. GC-MS identified
compounds were compared with the bacterial organic
volatile compounds included in the Microbial Volatile
Organic Compounds (mVOC) database (Lemfack et
al., 2014) as well as with those in the SuperScent
database (Dunkel et al., 2009).
Evaluation of antibacterial activity against
pathogens and microorganisms of the cave
For evaluation of antibacterial activity against
pathogens and microorganisms of the cave, the active
fractions, recovered from TLC plates and dissolved in
ethyl acetate, were used.
Antibacterial activity was determined against
Gram-positive pathogenic bacteria: Bacillus cereus
ATCC 10876 (Firmicutes), Enterococcus faecalis ATCC
29212 (Firmicutes), Listeria monocytogenes ATCC
7644 (Firmicutes), Staphylococcus aureus subsp.
aureus ATCC 25923 (Firmicutes), and Rhodococcus
equi ATCC 6939 (Actinobacteria). Agar-well diffusion
method was used for determination of the minimal
inhibitory concentration (MIC). The inocula of the
pathogenic bacteria were prepared in saline and
matched 0.5 McFarland standard. 19 mL of melted
and cooled down TSA medium was inoculated with
1 mL of such suspension and poured into Petri dish.
The final concentration of cells in TSA was 106 CFU/
mL. 5 mm diameter wells were cut in the inoculated
agar surface and filled with 100 μL of the sample. Six
different concentrations of antimicrobial compounds
were used for determination of MIC: 4.66 mg/mL (the
undiluted sample), 2.33 mg/mL (1:1 dilution), 1.165
mg/mL (1:3 dilution), 582.5 μg/mL (1:7 dilution),
291.25 μg/mL (1:15 dilution), and 145.625 μg/mL
(1:31 dilution).
In the current work antibacterial activity of the active
fractions was also examined against bacteria isolated
from Krubera-Voronja Cave: Gram-positive strain
28TSA30-8, Brevibacillus sp. 1410WF1-HT30-5,
Paenibacillus sp. 23TSA30-6, Paenibacillus sp.
28ISP30-5, and Streptomyces sp. 1350R2-SCNA30.
Modified agar-well diffusion method was used for this
test. Sterile TSA (20 mL) was poured into the Petri
dish, and the well was cut in agar in the centre of the
Petri dish. Bacterial cultures were streaked from the
edge of the well to the border of the Petri dish. Then the
well was filled with 100 μL of the sample containing
antimicrobial compounds at a concentration of 1.165
mg/mL. Growth inhibition indicated the antibacterial
activity of the tested compounds.

RESULTS
Isolation and antibacterial activity of microorganisms
from samples of Krubera-Voronja Cave
In total, 874 heterotrophic cultures were isolated
using five different media: TSA, HT agar, AI agar,
SCNA, and ISP4. 108 isolates were from water
samples, and 766 – from sediment samples collected
in Krubera-Voronja Cave at the depth from 220 m
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to 1640 m (Kieraite-Aleksandrova et al., 2015). The
largest number of cultures was isolated on TSA (93
isolates at 4°C and 141 ‑ at 30°C) and HT agar (207
isolates at 30°C). The smallest number of isolates
was obtained using AI agar – 138 at 30°C. In general,
temperature of 30°C was more suitable for the growth
of heterotrophs – 714 cultures were obtained at this
temperature, while only 160 cultures – at 4°C. Only
TSA and ISP4 were suitable for growth at the latter
temperature.
In order to examine antibacterial activity of the
isolated cultures, primary screening using agar
diffusion test was performed. Out of 874 cultures, 122
isolates (14.0%) demonstrated antibacterial activity.
108 active isolates were obtained from sediment
samples, and 14 – from water samples. Most (63.9%)
of the active isolates inhibited growth of a single test
microorganism, while four isolates possessed a broad
activity spectrum, being antagonistic against all test
microorganisms. Only 9.3% of isolates from the upper
part of the cave (sampling at 220-230 m in depth)
showed antimicrobial activity, while 11.1% and 14.1%
of all isolates from the middle (sampling at 500-700
m in depth) and lower (sampling at 1215-1640 m in
depth) parts of Krubera-Voronja Cave, respectively,
inhibited growth of at least one test strain.
Our previous cultivation-independent analysis
showed that Gram-positive phyla Actinobacteria and
Firmicutes were among the dominant phyla in KruberaVoronja Cave (Kieraite-Aleksandrova et al., 2015).
Therefore, we particularly focused on the isolates
that exhibited antagonism only against Gram-positive
but not against Gram-negative test microorganisms.
In total, 31 isolates inhibited growth of two different
test strains, and 24 of them were active only against
Gram-positive ones. Activity of most of these 24
isolates against both Gram-positive test strains was
very weak; somewhat stronger activity was observed
only for seven cave isolates. Two cave isolates,
1350R2-TSA30-6 and 1410WF1-TSA30-2, were
chosen for further experiments because of their high
and comparable activity against both Gram-positive
test strains – M. luteus from phylum Actinobacteria
and B. thuringiensis TL8 from phylum Firmicutes.
Both 1350R2-TSA30-6 and 1410WF1-TSA30-2 were
isolated on TSA at 30°C from samples 1350R2 and
1410WF1 that have been collected in the lower part
(1350 m and 1410 m depth) of Krubera-Voronja Cave.
Sample 1350R2 was the sample of white clay from the
rarely visited branch of the cave, and sample 1410WF1
was the sample of water from the underground camp
(Kieraite-Aleksandrova et al., 2015).
Genotyping and phylogenetic analysis
of active isolates
In order to determine whether isolates 1350R2TSA30-6 and 1410WF1-TSA30-2 represent two
different strains, BOX-PCR genotyping was performed.
Our analysis clearly showed that these two isolates
belong to two different strains (Fig. 1).
16S rRNA genes of these two strains were cloned,
sequenced and analysed. The BLAST search showed
that both strains belong to the family Bacillaceae
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in phylum Firmicutes. Both strains were assigned
to the genus Bacillus (Fig. 2). 16S rRNA gene of the
strain 1410WF1-TSA30-2 was most similar to those
of Bacillus aerophilus, Bacillus altitudinis and Bacillus
stratosphericus with 99.9% sequence similarity.
Strain 1350R2-TSA30-6 clustered with Bacillus
simplex, Bacillus frigoritolerans and Bacillus muralis
with 99.8%, 99.6% and 99.5% sequence similarity
respectively.
The effect of culture growth parameters for the
production of antibacterial compounds
Optimization experiments showed that growth
of a culture as well as production of antibacterial
compounds depended on the concentration of
nutrients in a culture medium. For the strain 1350R2TSA30-6, the highest optical density (OD600) as well
as the largest antimicrobial activity were observed in
0.5xTSB (data for BHIB not shown) (Fig. 3). For the
strain 1410WF1-TSA30-2, similar maximum OD600
and antibacterial activity were obtained in TSB and
0.5xTSB, but the growth rate was higher in 0.5xTSB
(Fig. 3). BHIB was the worst choice for the strain
1410WF1-TSA30-2 in terms of both culture growth
and antibacterial activity (data not shown). Therefore,
for both strains further optimization experiments
were carried out in 0.5xTSB.

Fig. 1. BOX-PCR electrophoretic profiles. M - GeneRuler
1 kb DNA Ladder (Thermo Fisher Scientific); 1 - 1350R2TSA30-6; 2 - 1410WF1-TSA30-2. The results of this test
indicate that isolates 1350R2-TSA30-6 and 1410WF1TSA30-2 are distinct.
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Fig. 2. Phylogenetic positions of strains 1350R2-TSA30-6 and 1410WF1-TSA30-2 as well as the nearest
neighbors from the family Bacillaceae. The numbers at the nodes represent percent of bootstrap values
obtained from 1000 samplings. Only the most significant values (higher than 70%) are presented.
Paenibacillus polymyxa DSM 36T was defined as an outgroup of the tree. Scale bar, 0.01 nucleotide
substitution per site.

Both the growth of a culture and the production of
antibacterial compounds were influenced by pH of a
culture medium. The best pH for the strain 1350R2TSA30-6 was pH 7, and for the strain 1410WF1-TSA30-2
it was pH 9. Aeration did not influence the results of our
experiments; highly similar results were obtained for
both 180 rpm and 250 rpm. Low (16°C) temperature was
not suitable for the growth of both strains – the strain
1410WF1-TSA30-2 did not grow, and OD600 for the
strain 1350R2-TSA30-6 at this temperature was ~3.3
times lower than at 30°C. Consequently, the growth in
the liquid culture at 8°C and 4°C was not tested.
Based on these results, both strains were further
cultivated in buffered 0.5xTSB at 30°C at 180 rpm.

pH of the medium was adjusted to 7 for cultivation of
the strain 1350R2-TSA30-6 and to 9 for cultivation
of the strain 1410WF1-TSA30-2. Growth curves and
antimicrobial activity, obtained after the optimization
experiments, are shown in Fig. 3. It is noteworthy
that for both strains the production of antimicrobial
compounds started in the exponential growth phase
and continued during the growth of the culture.
Extraction of antimicrobial compounds
Two different approaches were used for the
extraction of antimicrobial compounds from the
culture supernatant – salting-out with ammonium
sulphate and extraction by organic solvents.
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Characterization of antimicrobial
compounds
Antimicrobial
compounds
of
strains
1350R2-TSA30-6
and
1410WF1-TSA30-2
were analysed using TLC and bioautography.
Both strains showed two different fractions
on TLC plates, but only a single fraction of
each strain showed antimicrobial activity
against Gram-positive bacteria M. luteus
(Fig. 4). Retardation factor (Rf) of the compounds
with antimicrobial activity differed. Rf for the
compound of the strain 1350R2-TSA30-6 was
0.85, and for the strain 1410WF1-TSA30-2 it
was 0.93. The active compounds were recovered
from the TLC plates and analysed by GC-MS.
GC-MS was used to determine a chemical
composition of the two active TLC fractions. Main
components of the active fraction of the strain
1350R2-TSA30-6 were pyrrolizidines (Table 2,
compounds No. 8-12). Their total amount was
60.3%. For four peaks (RT 46.23, 49.58, 50.19,
and 58.70 min, compounds No. 8-11 in Table 2),
the highest match with the library data was for
pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3(2-methylpropyl)-. Clearly, those peaks should
represent four different compounds. We could
suppose that pyrrolo[1,2-a]pyrazine-1,4-dione,
Fig. 3. Optimization of the nutrient concentrations. Effect on the culture growth and
hexahydro-3-(2-methylpropyl)- corresponds to the
production of antibacterial compounds is shown. The width of inhibition zones is
expressed in millimeters and shown at the sampling points. “Optimal” is the growth
compound with RT 50.19 min (Table 2, compound
curve and antimicrobial activity under optimal conditions: 0.5xTSB in 50 mM TrisNo. 10), as its mass spectrum shows the highest
HCl, pH 7, 30ºC, 180 rpm for strain 1350R2-TSA30-6 and 0.5xTSB in 50 mM Trismatch with the library data. Other three peaks
HCl, pH 9, 30ºC, 180 rpm for strain 1410WF1-TSA30-2. “0.5xTSB“ is the growth
should correspond to the compounds with very
curve and antimicrobial activity under the following conditions: 0.5xTSB, pH 7
(unbuffered medium), 30ºC, 250 rpm for both strains. “TSB“ is the growth curve
similar structure, as their mass spectra are quite
and antimicrobial activity under the following conditions: 1xTSB, pH 7 (unbuffered
similar with a very intense fragment peak at
medium), 30ºC, 250 rpm for both strains.
m/z 154 that could be attributed to hexahydro
Salted-out extracellular proteins of strains 1350R2pyrrolo[1,2-a]pyrazine-1,4-dione (molecular mass
TSA30-6 and 1410WF1-TSA30-2 showed antibacterial
154). When harsh electron ionization is applied, the
activity against M. luteus (data not shown). The
compounds undergo fragmentation and their molecular
treatment with proteinase K did not diminish this
ions are not intense. Two of the compounds (with RT
activity. These experiments allowed us to suggest that
49.58 and 50.19 min – Table 2, compounds No. 9
antimicrobial compounds produced by both strains
and 10 respectively) have the same molecular ion
are not peptides or proteins.
with m/z 210 indicating that they could be isomers
Acetone, chloroform, ethyl acetate, methanol, and
of pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3hexane were used separately for extraction of the
(2-methylpropyl)-. A compound eluting at 46.23
different aqueous samples of the same culture by
min (Table 2, compound No. 8) has a molecular
organic solvents. All extractions were successful;
ion of m/z 196 and probably could be identified
antibacterial activity was detected in all extracts for
as pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3both strains. Antimicrobial activity of the extracts of
(2-isopropyl)-. A compound eluting at 58.70 min
the strain 1350R2-TSA30-6 was considerably higher
(Table 2, compound No. 11) has a low intensity
than of the extracts of the strain 1410WF1-TSA30-2.
molecular ion peak at m/z 343. Unfortunately,
It was detected that different extracts of the strain
very few mass spectra of related compounds can be
1410WF1-TSA30-2 exhibited comparable activity
found in the library, thus more precise identification
for all solvents used, while hexane and chloroform
was not possible. It should be noted that
extracts were the most active in the case of strain
pyrrolopyrazines
pyrrolo[1,2-a]pyrazine-1,4-dione,
1350R2-TSA30-6 (Table 1). So, chloroform extracts
hexahydro-3-(2-methylpropyl)- and pyrrolo[1,2-a]
were used for characterization of antimicrobial
pyrazine-1,4-dione,
hexahydro-3-(phenylmethyl)compounds produced by both strains.
are semivolatile cyclic dipeptides also called cyclo
Table 1. Antimicrobial activity of organic solvents’ extracts. Micrococcus luteus was used as the test microorganism in this
agar-well diffusion assay, the width of the inhibition zone is shown in millimeters.
Ethyl acetate

Acetone

Hexane

Chloroform

Methanol

1350R2-TSA30-6

Strain

1.5

3.0

4.0

3.5

2.0

1410WF1-TSA30-2

1.0

1.5

1.5

1.0

1.5
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Fig. 4. Thin layer chromatography and bioautography of chloroform
extracts. Micrococcus luteus was used for bioautography as the
test microorganism. Both 1350R2-TSA30-6 and 1410WF1-TSA30-2
showed two different fractions on TLC plates, but only a single fraction
of each strain showed antimicrobial activity.

(L-leucyl-L-prolyl) (or 2,5-diketopiperazine antibiotic
gancidin W) and cyclo(L-prolyl-D-phenylalanyl)
respectively.
Nineteen main compounds with the content of
≥0.5% were identified in active fraction of the strain
1410WF1-TSA30-2 (Table 3). The set of volatile
compounds differed for both strains, the only
common compound was 1,2-benzenedicarboxylic
acid, diisooctyl ester (Table 2, compound No. 13;
Table 3, compound No. 19). It should be noted, that only
some of the identified constituents of active fractions
were volatiles previously identified in other bacteria
(Tables 2, 3).
Spectrum of inhibitory activity
of antimicrobial compounds
The active TLC fractions of strains 1350R2TSA30-6 and 1410WF1-TSA30-2 were evaluated for
their antimicrobial activity against Gram-positive
pathogenic bacteria as well as against bacteria
isolated from Krubera-Voronja Cave.
The highest activity of active TLC fraction of the
strain 1350R2-TSA30-6 was observed against R. equi
ATCC 6939, while the lowest activity was recorded
against S. aureus subsp. aureus ATCC 25923 and
B. cereus ATCC 10876 (Table 4). The concentration
0.291 mg/mL was still inhibitory for all tested
pathogenic strains, except for S. aureus subsp.
aureus ATCC 25923. The MIC for the strain of S.
aureus subsp. aureus was 0.583 mg/mL, while for

other four pathogenic strains it was 0.291 mg/mL
(Table 4). It should be noted, that the active TLC fraction
was the only partially purified mixture of compounds,
therefore, the inhibitory concentrations could not be
evaluated for the discrete active compounds.
Antibacterial compounds of the strain 1350R2TSA30-6 also inhibited growth of other bacteria of
Krubera-Voronja Cave: Streptomyces sp. 1350R2SCNA30, Brevibacillus sp. 1410WF1-HT30-5, and
Paenibacillus sp. 23TSA30-6 (Fig. 5).
The active fraction of strain 1410WF1-TSA30-2
showed no antimicrobial activity against the tested
pathogenic bacteria. But antimicrobial compounds of
this strain had inhibitory effect on the growth of other
bacteria isolated from Krubera-Voronja Cave (Fig. 5).
Only Streptomyces sp. 1350R2-SCNA30 was resistant
to antibacterial compounds produced by the strain
1410WF1-TSA30-2.

DISCUSSION
For isolation of microorganisms from KruberaVoronja Cave, general purpose media (TSA) as well
as the growth media designed for the isolation and
cultivation of actinobacteria (HT agar, AI agar, SCNA,
ISP4) were used. The choice of the latter four media
was based on the well-known antimicrobial activity
of the members of phylum Actinobacteria (Rule &
Cheeptham, 2013). Nevertheless, the percentage
(14.0%) of Krubera-Voronja Cave isolates, that
produce antimicrobial compounds, was quite low and
comparable to some shallow caves: Backcountry Cave
(6 m in depth), Spider Cave (44 m in depth), and Fort
Stanton Cave (134 m in depth) – 21.1%, 19.8% and
8.6% respectively (Montano & Henderson, 2013). On
the other hand, data for some other shallow caves
show higher percentage of active isolates than of
Krubera-Voronja Cave: 66% for the Left Hand Tunnel
passage in Carlsbad Cavern (316 m in depth), 40%
for Lechuguilla Cave (489 m in depth) (Montano &
Henderson, 2013), 57% for Helmckens Falls Cave
(Rule & Cheeptham, 2013), 73.9% for Magura Cave
(56 m in depth) (Tomova et al., 2013). Our results
also showed that the percentage of bacteria capable of
antagonistic activity increased from the upper to the
lower part of the cave. These results were in accordance
with the findings of Montano & Henderson (2013)
who revealed that the increasing depth influenced the
antimicrobial activity of the cave isolates. To the best
of our knowledge, our present study is the first report
on the antimicrobial activity of bacterial isolates in
Krubera-Voronja Cave.

Table 4. Antibacterial activity of the active TLC fraction of strain 1350R2-TSA30-6 against pathogenic bacteria. The width of the inhibition
zone is shown in millimeters.
The concentration of the antimicrobial compounds
in ethyl acetate, mg/mL

Pathogen

4.660

2.330

1.165

0.583

0.291

0.146

6.5

6.0

5.0

3.0

2.0

0

Enterococcus faecalis ATCC 29212

10.0

7.0

5.0

4.0

2.0

0

Listeria monocytogenes ATCC 7644

7.0

6.5

5.0

3.5

3.0

0

Staphylococcus aureus subsp. aureus ATCC 25923

3.5

1.5

0.5

0.5

0

0

12.0

8.0

5.5

5.0

3.0

0

Bacillus cereus ATCC 10876

Rhodococcus equi ATCC 6939
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2012); macrolide antibiotics macrolactins 1-3
produced by Bacillus sp. (Mondol et al., 2011);
macrolides gageomacrolactins 1-3 produced
by B. subtilis (Tareq et al., 2013). Therefore,
production of both antimicrobial peptides
and non-peptide antibiotics was expected for
bioactive strains from Krubera-Voronja Cave.
The antimicrobials of strains 1350R2TSA30-6 and 1410WF1-TSA30-2 differed
significantly. The active compounds behaved
differently in some organic solvents during
extraction as well as had different Rf values
in TLC. It was also noticed that antimicrobial
substances of the strain 1350R2-TSA30-6
Fig. 5. Antibacterial activity of active TLC fractions against bacteria isolated from Kruberawere stable, and the inhibition zone was
Voronja Cave. The concentration of antimicrobial compounds in ethyl acetate was 1.165
mg/mL. 1 – Streptomyces sp. 1350R2-SCNA30; 2 – Brevibacillus sp. 1410WF1-HT30-5;
visible constantly during the growth of
3 – Gram-positive strain 28TSA30-8; 4 – Paenibacillus sp. 28ISP30-5; 5 – Paenibacillus
the test microorganism in bioautography
sp. 23TSA30-6.
experiments, while antimicrobial substances
The other focus of our research was the antibacterial
of the strain 1410WF1-TSA30-2 inhibited the test
activity targeting Gram-positive bacteria. It should be
microorganism only at the first stages of its growth,
noted that Gram-positive pathogens are a major cause
but disappeared through further cultivation due to
of nosocomial bacterial infections. Staphylococci,
evaporation of active compounds or their inactivation
enterococci, streptococci, and Clostridium difficile
by the growing culture of M. luteus (data not shown).
are the most important species of clinical interest
Activity of antimicrobials of the strain 1350R2(Rossolini et al., 2014). Antibiotic resistance issues
TSA30-6 was higher than of strain 1410WF1-TSA30-2.
are common among Gram-positive pathogens, and
The common characteristics for both strains included
the percentage of nosocomial infections caused
poor production of antimicrobials in a highly rich
by antibiotic-resistant Gram-positive bacteria is
growth medium BHIB as well as continued production
increasing. For example, in the United States,
of active compounds during the growth of the culture
approximately 60% of staphylococcal infections are
starting in the exponential growth phase. The first
now caused by multidrug-resistant S. aureus, and
characteristic can be associated with the need to
these percentages continue to rise (Rice, 2006).
produce antimicrobials under starvation, but not
Therefore, the development of novel antibiotics that
under the nutrient-rich growth conditions (Montano
would be active against Gram-positive pathogens
& Henderson, 2013). The second feature (the time of
is imperative. Only a small portion (24 out of 874)
production) indicated that antimicrobial compounds
of bioactive isolates were antagonistic exclusively
(or at least some of them) were primary metabolites
against Gram-positive bacteria, moreover – the
(Sanchez & Demain, 2008).
bioactivity of the most of these 24 isolates was very
Chemical compounds in the active TLC fractions
weak. Two most active strains 1350R2-TSA30-6 and
of both strains differed markedly. The main
1410WF1-TSA30-2, isolated from the lower part of
antibacterial agents of the strain 1350R2-TSA30-6
the cave, were chosen for detailed characterization of
were 2,5-diketopiperazine antibiotics. Most of
the antimicrobials. It is of interest that these strains,
2,5-diketopiperazines are stable to proteolysis (Pérezalthough antagonistic against Gram-positive test
Picaso et al., 2009), and we have also observed this
strains M. luteus and B. thuringiensis TL8, were also
effect after treatment of the salted-out extracellular
Gram-positive ‑ both strains were assigned to the
proteins of the strain 1350R2-TSA30-6 with proteinase
genus Bacillus.
K. Antitumor, antifungal, antiviral, and antibacterial
Bacteria of the family Bacillaceae are mainly known
activities of cyclic dipeptides are well-known (Yan
for their antimicrobial peptides – both ribosomally
et al., 2004; Pandey et al., 2010; de Carvalho &
and nonribosomally synthesized peptide antibiotics.
Abraham, 2012; Kumar et al., 2014). Cyclic dipeptides
Nonribosomally synthesized antibiotic bacitracin A
are usually produced by Gram-negative bacteria, but
is produced by Bacillus licheniformis, lipopeptides
have been also isolated from Gram-positive. Among
surfactin, iturin, bacillomycin, and fengycin are
the genera of the family Bacillaceae, they were so
produced by several strains of Bacillus subtilis.
far identified only in the genus Bacillus (de Carvalho
Well-known
ribosomally
synthesized
peptides
& Abraham, 2012; Leyton et al., 2012). Because of
(bacteriocins) of Bacillaceae include subtilin and
their activity spectrum, cyclic dipeptides attract much
subtilosin A from B. subtilis; coagulin from Bacillus
attention as potential pharmaceuticals. Our results
coagulans; bacthuricin F4, thuricin 17, entomocin
clearly showed that antibacterial fraction of the
9, and tochicin from B. thuringiensis; cerecin 7
strain 1350R2-TSA30-6 was active against Gramfrom B. cereus; bacillocin 490 from B. licheniformis
positive pathogenic bacteria B. cereus, E. faecalis, L.
(Sumi et al., 2015). On the other hand, bacilli also
monocytogenes, S. aureus subsp. aureus, and R. equi.
produce non-peptide antimicrobial compounds,
Cyclic dipeptides are secondary metabolites (Leyton
such as bis (2-ethylhexyl) phthalate, synthesized by
et al., 2012), therefore, if they would be the only
Bacillus pumilus (Moushumi Priya & Jayachandran,
compounds with bioactivity, then the antimicrobial
International Journal of Speleology, 45 (3), 275-287. Tampa, FL (USA) September 2016
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effect would appear only in the stationary phase
of the culture growth. But antimicrobial activity
was also detected in the exponential growth phase
of the strain 1350R2-TSA30-6. We have concluded that
other volatile compounds, identified in an active fraction
of this strain, were responsible for this early effect. For
example, antibacterial, antiviral, or antifungal activities
were previously reported for 1,2-benzenedicarboxylic
acid, diisooctyl ester (Rameshthangam & Ramasamy,
2007; Maruthupandian & Mohan, 2011) and
1,3-dimethyl-benzene (El-Shouny et al., 2014). Some
compounds (ethylbenzene, p-xylene) were previously
identified in mixtures of bacterial volatiles (TenorioSalgado et al., 2013), while others (cyclohexanone)
‑ in plant extracts (Kim et al., 2011) possessing
antimicrobial activity.
GC-MS results for the strain 1410WF1-TSA30-2
markedly differed from the results for strain 1350R2TSA30-6. The only common antimicrobial compound
was 1,2-benzenedicarboxylic acid, diisooctyl ester.
Cyclic dipeptides were not found, but a range of other
compounds with different bioactivities were identified.
Antibacterial, antiviral, antifungal, or antioxidant
activities were previously reported for dibutyl phthalate
(Maruthupandian & Mohan, 2011), nonadecane
(Fernando et al., 2005), phenol, 2,4-bis(1,1dimethylethyl)- (Varsha et al., 2015). Some compounds
(hexadecane, octadecane) were previously identified
in antimicrobial or nematicidal mixtures of bacterial
volatiles (Gu et al., 2007; Karanja et al., 2010), while
others (1-nonadecene, 2-methyl-eicosane) ‑ in plant
extracts with antibacterial activity (Boussaada et al.,
2008). The main compounds in antibacterial mixture of
volatiles of the strain 1410WF1-TSA30-2 were benzoic
acid, octadecyl ester and 1,2-benzenedicarboxylic
acid, bis(2-methylpropyl) ester. We could not find any
information about putative antimicrobial activity of
octadecyl benzoate; it was not listed among bacterial
volatiles in the mVOC and SuperScent databases either.
But the esters of 1,2-benzenedicarboxylic acid (bis(2ethylhexyl) ester, bis(2-methylpropyl) ester, butyl-2methylpropyl ester, butyl-2-ethylhexyl ester, diisooctyl
ester, etc.) are frequently the main components of
antibacterial and antifungal mixtures of volatiles from
different sources: algae (Sivakumar, 2014), plants
(Joshi et al., 2011), fungi (Nakalembe & Kabasa, 2012),
bacteria (El-Mehalawy et al., 2008). Actually these esters
are believed to be responsible for antimicrobial activity
of these mixtures of volatiles. Antiviral, antifungal,
and antibacterial activities were demonstrated for
1,2-benzenedicarboxylic acid, bis(2-ethylhexyl) ester;
while antimicrobial, antioxidant, and antitumor
activities were shown for 1,2-benzenedicarboxylic
acid, mono(2-ethylhexyl) ester (Kavitha et al., 2009;
Karthikeyan et al., 2014). Antibacterial and antifungal
activities were confirmed for 1,2-benzenedicarboxylic
acid, bis(5-ethylheptyl) ester (Kavitha et al., 2009).
1,2-benzenedicarboxylic acid, bis(2-methylpropyl)
ester, found in active antibacterial fraction of the strain
1410WF1-TSA30-2, had been also identified in a few
other representatives of the genus Bacillus (Hao & Lu,
2007; Mallaiah & Muthamilan, 2015).
It is known that bacteria use volatile metabolites for

inter- and intraspecific communications as well as in
order to respond and adapt to environmental changes
(Audrain et al., 2015). Microorganisms in caves form
multispecies communities with complex interaction
networks among their members, and bacterial volatile
mixtures can participate in these interactions. For
example, it had been previously shown that Bacillus
sp. can start producing cyclic dipeptides when
challenged by a co-culture of other Bacillus species
(de Carvalho & Abraham, 2012). Our results showed
that antimicrobial volatile mixtures of strains 1350R2TSA30-6 and 1410WF1-TSA30-2 could be also involved
in the competition and engagement with other bacterial
species in Krubera-Voronja Cave. The strains of Grampositive genera Paenibacillus and Brevibacillus (phylum
Firmicutes, family Paenibacillaceae) were sensitive to
active antimicrobial fractions of both strains isolated
from the same cave. The main difference between
volatiles of both investigated strains was in their
antagonism against actinobacterial strain of the genus
Streptomyces. It is interesting that antimicrobial
compounds of the strain 1410WF1-TSA30-2 were
antagonistic against bigger number of cave strains
than antimicrobial compounds of the strain 1350R2TSA30-6. This is contrary to the zero antimicrobial
activity of volatiles of the strain 1410WF1-TSA30-2
against pathogenic bacteria. It was supposed that
the primary role of volatiles of the strain 1410WF1TSA30-2 is the competition with the indigenous Grampositive microorganisms of the cave.
In conclusion, our results clearly demonstrated
that while screening for novel bioactive compounds,
examining the lesser-studied phyla, such as Firmicutes,
rather than the commonly examined Actinobacteria
is an important and promising approach. Cave
actinobacteria are usually the main targets of
bioactivity assays, and therefore the antimicrobial
potential of other bacteria is underestimated. Detailed
analysis of two Firmicutes strains, isolated from
Krubera-Voronja Cave, revealed two different mixtures
of compounds with antibacterial activity. The main
antibacterial compounds of the strain 1350R2-TSA30-6
were pyrrolopyrazines, and the main antibacterial
compound of the strain 1410WF1-TSA30-2 was bis(2methylpropyl) ester of 1,2-benzenedicarboxylic acid.
To the best of our knowledge, our study is the first
report on chemical characterization of antimicrobial
mixtures of Firmicutes isolated from caves.
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